However, I can't see how the existence of other smartphone - related patents (
utility patents as well as design patents) would not have probative value: the single strongest argument for a narrowly - defined article of manufacture (just the casing) simply is that there is so much more in and on a smartphone than just a very few, narrow designs.
Not exact matches
As Scott explains, they «contain 30 or more chapters providing special protections for foreign investors; extending patents and copyrights; privatizing markets for public services such as education, health, and public utilities; and «harmonizing» regulations in ways that limit or prevent governments from protecting the public health or environment.&raqu
As Scott explains, they «contain 30 or more chapters providing special protections for foreign investors; extending
patents and copyrights; privatizing markets for public services such
as education, health, and public utilities; and «harmonizing» regulations in ways that limit or prevent governments from protecting the public health or environment.&raqu
as education, health, and public
utilities; and «harmonizing» regulations in ways that limit or prevent governments from protecting the public health or environment.»
A fundamental analysis of cryptocurrencies and blockchain projects involves indicators like conference announcements, forks,
as well
as new coin listings, technology
patents, user base, size of network, and token
utility.
Use or post, without authorization, any content protected by law (e.g. copyright, trademark,
patent,
utility patent, design
patent or other intellectual property (IP) laws), or advertise, promote, offer or distribute any goods or services protected by law; v. Use, post or promote any commercial practices considered unfair competition, including progressive customer acquisition practices (such
as chain distribution systems, Ponzi schemes, illegal multi-level selling or pyramid sales).
As Gary Stix reviewed in «Owning the Stuff of Life,» in the February issue, companies and universities have been on a spree of
patenting not only whole genes but also genetic fragments of unknown
utility.
Speaking at the annual meeting of the American Association for the Advancement of Science (which publishes ScienceNOW), PTO acting deputy commissioner of
patents and trademarks Lawrence Goffney said that the office «has decided to allow claims to ESTs based on their
utility as probes.»
In letters and speeches, both have argued that only inventors who clearly describe the «
utility» of a gene, such
as a plan to develop a medical product, deserve to win a
patent.
But,
as Microsoft argued, it is § 271 that sets forth the standard for infringement of design
patents — just like it does for
utility patents.
For
patents that rely upon sound prediction, the
utility analysis asks whether the
patent specification
as filed supports the inventor's prediction, not whether the invention ultimately achieves commercial success.
Moreover, the specific disclosure requirements for
patents where
utility is based on sound prediction is the consideration an inventor pays for obtaining a
patent without having proved actual
utility as at the filing date of the
patent application.
As is common in the pharmaceutical industry, both
patents relied upon the doctrine of sound prediction to establish
utility.
The German
patent office will most likely treat the Federal Patent Court's opinion on the photo gallery patent as binding case law for the purposes of the utility model revocation proceedings; if not, Apple can always ask the Federal Patent Court to review the decision, and a panel presumably consisting of partly the same people would probably affirm the previous decision in the new co
patent office will most likely treat the Federal
Patent Court's opinion on the photo gallery patent as binding case law for the purposes of the utility model revocation proceedings; if not, Apple can always ask the Federal Patent Court to review the decision, and a panel presumably consisting of partly the same people would probably affirm the previous decision in the new co
Patent Court's opinion on the photo gallery
patent as binding case law for the purposes of the utility model revocation proceedings; if not, Apple can always ask the Federal Patent Court to review the decision, and a panel presumably consisting of partly the same people would probably affirm the previous decision in the new co
patent as binding case law for the purposes of the
utility model revocation proceedings; if not, Apple can always ask the Federal
Patent Court to review the decision, and a panel presumably consisting of partly the same people would probably affirm the previous decision in the new co
Patent Court to review the decision, and a panel presumably consisting of partly the same people would probably affirm the previous decision in the new context.
We note that the standard for showing
utility for a compound
as a pharmaceutical before the
patent office is much lower than that before the FDA, and that a human clinical trial is not necessary to establish
utility for an invention related to treatment of human disorders.
This ruling is not thermonuclear on its own, but in its aftermath, we will not only see a lot of wrangling over a judgment
as a matter of law to overrule the jury and over injunctive relief but there will also be, even more importantly, a push by Apple to enforce many more design
patents and
utility (hardware and software)
patents against Samsung.
SOUTHFIELD, Mich. — Brooks Kushman is pleased to announce that the firm has been ranked by IP Watchdog
as the 28th Top
Patent Firm for 2017 based on utility patent fi
Patent Firm for 2017 based on
utility patent fi
patent filings.
He provides advice regarding optimal IP protection and assistance in
patent and UM drafting, prosecution and litigation
as well
as invalidation of inaccurately granted
patents and rights under
utility designs.
He provides advice regarding optimal IP protection and assistance in
patent and UM drafting, prosecution and litigation
as well
as invalidation of inaccurately granted
patents and rights under
utility models.
Just
as Eli Lilly unfortunately found in atomoxetine, it is very difficult to switch from an unsuccessful argument for actual
utility to sound prediction — because one is left with only the disclosure of the
patent (and not the extensive tests relied on for actual secret
utility).
Although finding a compound
patent valid based on actual
utility after construing a low Promise, Mr. Justice Rennie recognized (in obiter) there would be problems with a sound prediction of any higher Promise, and referred to the «common view» of the disclosure requirement of AZT
as follows:
As of Friday, July 1, «the application size fee for electronically filed
utility and provisional
patent applications will be based on 75 % of the number of pages for the paper size equivalent of the specification (including claims) and drawings, and any external tables,» writes Bill Heinze.
The promise doctrine was developed through the Federal Courts» jurisprudence; under it, a judge reviewed a
patent as a whole to identify any «promises» made in it, then assessed whether those promises had been met in order to satisfy the utility requirement of the patent under the Paten
patent as a whole to identify any «promises» made in it, then assessed whether those promises had been met in order to satisfy the
utility requirement of the
patent under the Paten
patent under the
PatentPatent Act.
He has written and prosecuted design and
utility patents for clients in industries such
as automotive, construction, consumer products, manufacturing and sporting goods.
Such a disgorgement is only permissible if at least one design
patent was infringed (it's impermissible for infringement of
utility patents) and (which is not specific to design
patents but to all
patent damages under 35 U.S.C. § 287 (a)-RRB- if the infringer had «actual or constructive notice of the
patent» (
as Judge Koh described the requirement in her damages order).
A
Utility patent protects new and useful machines, processes and chemicals,
as well
as improvements to these things.
As such, the
patent priority date is an important factor for the examination process through which the
utility patent undergoes.
The Tribunal characterized the three elements of the promise doctrine
as: (i) the identification of a «promise» in the
patent disclosure, against which
utility is measured; (ii) the prohibition on the use of post-filing evidence to prove
utility; and (iii) the requirement for pre-filing evidence to support a sound prediction of
utility to be included in the
patent disclosure.
In Sanofi v Apotex 2013 FCA 186 (Plavix / clopidogrel)[5], the appellate court defined «The Promise»
as «the standard against which the
utility of the invention described in the
patent is measured».
Significantly the Federal Court of Appeal emphasized: (1) only if an inventor makes «an explicit promise of a specific result, then
utility will be assessed by reference to the terms of the explicit promise»; (2)
as there is no obligation to disclose
utility in a
patent, one can not assume every
patent has an explicit promise; and (3) where there is no explicit promise, a «mere scintilla» of
utility will suffice.
As clarified by the Government of Canada in its reply factum, in fact three Canadian
patents have been invalidated solely on the basis of
utility since 2005 — two of which are Eli Lilly's
patents that are the subject of its NAFTA challenge.
Notably, the SCC provided a new approach to determining
utility: (1) identify the subject - matter of the invention
as claimed in the
patent; and (2) ask whether that subject - matter is useful — is it capable of a practical purpose (an actual result).
The monopoly provided by a
patent lasts 20 years for
utility patents (
as long
as the proper maintenance fees are paid on time) and 14 years for design
patents.
Further, let us not forget that the SCC has on multiple occasions reaffirmed the principle that a mere scinitilla of
utility is needed for
utility to be demonstrated, which is a fundamental aspect of Canadian
as well
as European and U.S
patent law.
Although the SCC has recently granted leave in Astra's esomeprazole action [12], both parties have acknowledged in their leave materials that the disclosure requirement is not determinative in this case (
as the lower court held there was no sound prediction of the promised
utility relying on material in the
patent as well
as Astra's internal tests).
There is a need for some explicit direction on the proper framework
as to what needs to be in a
patent and / or the public realm and / or inhouse tests in order to render a prediction of a certain promised
utility sound.
Of course this isn't news to Patently Mobile,
as our
utility patent archive illustrates many of Samsung's concepts
as well
as their design
patents.
While it's always tempting for the Apple side of the competiton to say that Samsung has tried to copy something of Apple's such
as the Apple Watch's Digital Crown in some way, the fact is that the
utility and design
patents behind this new design surfaced back in June and July 2014, well ahead of Apple's revelations of the Apple Watch with its Digital Crown.
Even though many
patent professionals refers to design
patents as «picture
patents,» potential patentees should be aware that design
patents can provide overlapping protection if used in tandem with
utility patents.
The jury also found that Apple proved by clear and convincing evidence that Samsung infringement was willful
as to all the
utility patents at issue, in addition to the design
patents on the iPhone.
That may be about to change, however,
as AppleInsider reports that Apple has added both the Samsung Galaxy S III and the Galaxy Note to a separate complaint that it filed this past February that asserted eight
utility patents against 17 different Samsung products.